Skip to content
Search

Latest Stories

Mistura offers free software to support frontline staff during Covid-19

In a bid to support frontline staff during Covid-19 pandemic, Mistura Informatics is offering an online resource, Medicines: A Patient Profile Summary (MaPPs) to provide up-to-date information on medicine to the NHS.

The online resource, being offered for three months free of charge, will reduce pressure on frontline staff and free up time during the Covid-19 crisis, the company has said.


This will also enable staff who have been redeployed to new, unfamiliar roles to have the most up-to-date drug information at their fingertips to share with patients on discharge, the company has said.

MaPPs is currently installed in over 100 organisations, including hospital trusts, pharmacies, and Clinical Commissioning Groups (CCG’s), with a further 58 brought on board since the service has been made available.

As an online tool that enables remote access to medicines information anytime and anywhere, MaPPs can help facilitate this change in service delivery and accommodate Covid-19 restrictions.

Developed by former NHS pharmacist and company founder Dawn Price, MaPPsis an online resource that provides a simplified300-word patient information summary on over 6,000 medicines available in the UK.

Commenting on the product, Price said: “…MaPPs reduces the time spent explaining medicines to patients, making the hospital discharge service faster and more efficient. Safeguarding patient’s wellbeing is critical during this crisis, andour software will give people the tools to take their medication safely and effectively while they are in social isolation with a clear written record.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less